Research & Development

The blending of carefully selected internal development activities, complemented by highly focused associations with innovative development partners and medical specialists.

In order to fulfill our goal of providing a constant supply of new, innovative products to improve clinical outcomes, be responsive to the needs of health care practitioners and sensitive to issues of patient comfort, while controlling the costs of that care, we utilize the skill and innovative capabilities of our research and development organization, supplemented by a significant program to identify, acquire and develop important new technologies and products which were conceived outside the Corporation.

Click here for information on the Idea Generation Process

Bard leverages its capabilities in product development, and its demonstrated ability to commercialize products in a timely fashion to attract suitable partners from the academic, practitioner and industrial communities to insure that products and product development opportunities from other organizations will properly supplement its internal development efforts.

One of our most critical components of revenue growth strategy is our ability to identify, manufacture and market innovative, technology-based solutions to treat disease and disability.   Bard's significant increase in R&D investment in recent years- from $53 million in 2001 to $135 million in 2007 - is a measure of our commitment to innovation and evidence of our ability to execute growth strategy.

In recent years, our increased focus on R&D has yielded some significant results.  We have strengthened our infrastructure- creating an interactive R&D Council to share diverse experiences, and leverage ideas and best practices among our divisions.   The council has designed a portfolio management tool to measure improvement and effectiveness in our product development process, and as a result, our product development pipeline has increased to more than 150 active projects.